Step pharmaceutical: bc004 drug for injection clinical trial approved
According to the pharmaceutical announcement, the company's bc004 for injection obtained the notice of approval for drug clinical trial. BC004 is mainly used for the treatment of HER2 positive late solid tumors, including HER2 positive breast cancer, gastric cancer / gastroesophageal junction adenocarcinoma and so on. At present, there are no drugs on the market with the same target at home and abroad.
Briefing Mar 21, 2025 05:14 PM
· Technology
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
In-depth
Briefing Jun 27, 2022 12:55 PM
· Automotive
Nezha automobile: it will quickly start the joint-stock system reform of the company
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 05, 2023 07:33 PM
Briefing Apr 02, 2022 07:38 PM
· Financials
The Russian Federal reconnaissance Commission launched a criminal investigation into the Ukrainian army's attack on the oil depot in the Belgorod region
Briefing Mar 15, 2022 07:58 AM
· Technology
Semiconductor manufacturer Semtech issues price increase notice
Briefing Feb 15, 2022 08:09 AM
· Consumer Staples
Haitong Securities: the peak time of steel carbon is delayed, which is good for the demand and valuation of coal coke in the long run
Briefing Dec 28, 2021 08:38 PM
· Technology
Zhou Hongyi: the yuan universe was "suppressed" during the epidemic
Consumer Staples, Financials · Analysis
EqualOcean Presents: China Big Tech Crackdown Winners
This research report gathers all the information you need to understand the recent antitrust regulation shifts in China and analyzes ten companies that are likely to win big from them.
Jul 12, 2021 12:11 AM
Insight
Briefing Nov 02, 2021 12:23 PM
· Financials
UnionPay business: reduce the handling fees paid by small and micro enterprises and individual industrial and commercial households
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
China’s “Dark Cuisine” and Southeast Asia’s Wealth Code
Yesterday 03:46 PM
Insight
In-depth
Insight
In-depth